The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCAY.L Regulatory News (CAY)

  • There is currently no data for CAY

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

De-listing and cancellation of trading of shares

24 Jan 2022 07:05

RNS Number : 2806Z
Charles Stanley Group PLC
24 January 2022
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF THAT JURISDICTION

FOR IMMEDIATE RELEASE

24 January 2022

 

DE-LISTING AND CANCELLATION OF TRADING OF CHARLES STANLEY SHARES

Further to the announcements made by Charles Stanley Group PLC ("Charles Stanley") and Raymond James Financial, Inc. ("Raymond James") on 21 January 2022 in respect of the Effective Date of the Scheme, Charles Stanley announces that, following an application on behalf of Charles Stanley, the Financial Conduct Authority ("FCA") has cancelled the listing of Charles Stanley Shares on the premium listing segment of the Official List and the London Stock Exchange (the "LSE") has cancelled the admission to trading of Charles Stanley Shares on the Main Market of the LSE for listed securities, in each case with effect from 8.00 a.m. on 24 January 2022.

Capitalised terms used but not otherwise defined in this announcement have the meanings given to them in the scheme document published by Charles Stanley on 25 August 2021.

 

Enquiries:

Charles Stanley Group PLC

+44 0 20 7739 8200

Paul Abberley, Chief Executive Officer

Ben Money-Coutts, Chief Financial Officer

N.M. Rothschild & Sons Limited

(Lead financial adviser to Charles Stanley) 

+44 0 20 7280 5000

Jonathan Eddis

Peel Hunt LLP

(Joint financial adviser and broker to Charles Stanley)

+44 0 20 7418 8900

Andrew Buchanan

James Britton

Raymond James Financial, Inc.

 +1 727 567 1000

Alexandra Band, Senior Vice President, Head of Corporate

Development

 

Lars Moore, Vice President, Corporate Development

Raymond James Financial International Limited

(Financial adviser to Raymond James and Bidco)

+44 0 203 798 5700

Edward Griffin

Jack Wills

Norton Rose Fulbright LLP is retained as legal adviser to Charles Stanley.

Skadden, Arps, Slate, Meagher & Flom (UK) LLP is retained as legal adviser to Raymond James.

 

Important notices relating to financial advisers

Raymond James Financial International Limited ("RJFIL"), which is authorised and regulated by the FCA in the United Kingdom, is acting exclusively for Raymond James and Bidco as financial adviser and no one else in connection with the Acquisition and other matters set out in this announcement and will not be responsible to anyone other than Raymond James and Bidco for providing the protections afforded to clients of RJFIL, or for providing advice in connection with the Acquisition, the content of this announcement or any matter referred to herein. Neither RJFIL nor any of its subsidiaries, affiliates or branches owes or accepts any duty, liability or responsibility whatsoever (whether direct, indirect, consequential, whether in contract, in tort, under statute or otherwise) to any person who is not a client of RJFIL in connection with this announcement, any statement contained herein or otherwise.

N.M. Rothschild & Sons Limited ("Rothschild & Co"), which is authorised and regulated by the FCA in the United Kingdom, is acting exclusively for Charles Stanley and for no one else in connection with the Acquisition and will not regard any other person as its client in relation to the Acquisition and will not be responsible to anyone other than Charles Stanley for providing the protections afforded to clients of Rothschild & Co, nor for providing advice in relation to any matter referred to in this announcement.

Peel Hunt LLP ("Peel Hunt"), which is authorised and regulated in the United Kingdom by the FCA, is acting exclusively for Charles Stanley and for no one else in connection with the matters described in this announcement and will not regard any other person as its client in relation to the matters referred to in this announcement and will not be responsible to anyone other than Charles Stanley for providing the protections afforded to clients of Peel Hunt nor for providing advice in relation to matters described in this announcement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDKZGZMDMGGZZM
Date   Source Headline
24th Jan 20227:05 amRNSDe-listing and cancellation of trading of shares
21st Jan 20227:35 amRNSScheme Effective Announcement
19th Jan 20223:56 pmRNSRule 2.9 Announcement
19th Jan 202212:18 pmRNSCourt sanction of Scheme of Arrangement
19th Jan 202212:00 pmRNSForm 8.5 (EPT/RI) - Charles Stanley Group Plc
19th Jan 20228:51 amRNSForm 8.3 - Charles Stanley Group Plc
18th Jan 20225:12 pmRNSForm 8.3 - Charles Stanley Group plc _Replacement
18th Jan 20223:30 pmRNSForm 8.3 - CAY LN
17th Jan 20224:17 pmRNSTransaction Notification - SIP Dividend Purchase
17th Jan 20223:09 pmRNSForm 8.3 - CHARLES STANLEY GROUP PLC
17th Jan 202212:00 pmRNSForm 8.5 (EPT/RI) - Charles Stanley Group Plc
17th Jan 202211:35 amRNSForm 8.3 - CHARLES STANLEY GROUP PLC
17th Jan 202211:08 amRNSForm 8.3 - Charles Stanley Group PLC
14th Jan 20223:35 pmRNSTransaction Notification - SIP Purchase Jan 2022
11th Jan 202211:30 amRNSHolding(s) in Company
5th Jan 20223:30 pmRNSForm 8.3 - Charles Stanley Group plc
21st Dec 20214:08 pmRNSForm 8.3 - CAY LN
21st Dec 20213:48 pmRNSForm 8.3 - CAY LN
21st Dec 20211:35 pmRNSApproval from the Financial Conduct Authority
20th Dec 20213:30 pmRNSForm 8.3 - CAY LN
20th Dec 202111:07 amRNSForm 8.5 (EPT/RI)
17th Dec 20213:30 pmRNSForm 8.3 - CAY LN
17th Dec 202110:23 amRNSForm 8.3 - Charles Stanley Group PLC
14th Dec 20214:22 pmRNSChange to Board Role
14th Dec 20213:30 pmRNSForm 8.3 - CAY LN
14th Dec 202112:48 pmBUSForm 8.3 - CHARLES STANLEY GROUP PLC
13th Dec 202112:07 pmBUSFORM 8.3 – CHARLES STANLEY GROUP PLC
13th Dec 202111:18 amRNSForm 8.5 (EPT/NON-RI)
13th Dec 20217:00 amRNSAnnouncement on updated Scheme timetable
10th Dec 20213:05 pmRNSForm 8.3 - Charles Stanley Group PLC
10th Dec 20212:08 pmBUSForm 8.3 - CHARLES STANLEY GROUP PLC
10th Dec 20212:04 pmRNSDirector/PDMR Shareholding
10th Dec 20219:10 amRNSForm 8.5 (EPT/RI)
8th Dec 202111:21 amBUSFORM 8.3 – CHARLES STANLEY GROUP PLC
2nd Dec 202112:00 pmRNSForm 8.5 (EPT/RI) - Charles Stanley Group Plc
30th Nov 20214:28 pmRNSDirectorate and Board Committee Changes
30th Nov 20213:16 pmRNSTotal Voting Rights
29th Nov 202112:15 pmBUSFORM 8.3 – CHARLES STANLEY GROUP PLC
26th Nov 202112:00 pmRNSForm 8.5 (EPT/RI) - Charles Stanley Group Plc
25th Nov 20214:33 pmRNSAnnouncement regarding interim dividend
25th Nov 20212:38 pmRNSForm 8.3 - CAY LN - Replacement
25th Nov 20211:30 pmRNSForm 8.3 - CAY LN
25th Nov 202111:50 amRNSForm 8.3 - CHARLES STANLEY GROUP PLC
24th Nov 20216:25 pmBUSForm 8.3 CHARLES STANLEY GROUP PLC
23rd Nov 202112:02 pmBUSFORM 8.3 - CHARLES STANLEY GROUP PLC
23rd Nov 202111:24 amRNSForm 8.5 (EPT/RI)
22nd Nov 202112:11 pmBUSFORM 8.3 - CHARLES STANLEY GROUP PLC
22nd Nov 202111:43 amRNSForm 8.3 - CHARLES STANLEY GROUP PLC
22nd Nov 202111:25 amRNSForm 8.3 - Charles Stanley Group Plc
22nd Nov 20219:28 amRNSForm 8.5 (EPT/RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.